Infrastructure Management and Extreme Events

Funding Opportunity Number: PD-15-1638 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 47.041Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: NSFClosing Date: Feb 17, 2015Award Ceiling: Expected Number of Awards: 0Creation Date: Dec 08, 2014Funding Opportunity Description: The IMEE program supports fundamental, multidisciplinary research on the impact of hazards and extreme events upon civil infrastructure and society. The program is focused upon research on the mitigation of, preparedness for, response to, and recovery from multi-hazard disasters. Community and societal resilience and sustainability are important topics within the research portfolio of IMEE. The program is deeply multidisciplinary and attempts to integrate multiple issues from civil, mechanical, transportation, and system engineering, sociology, psychology, economics, geography, political science, urban planning, epidemiology, natural and physical science, and computer science. With regard to the four core emphasis areas of mitigation, preparedness, response and recovery, a variety of topics are supported. The following list provides examples of the kinds of topics and issues that may be supported, though the list is not exhaustive and othe...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding

Related Links:

Called Winship at Midtown, the nearly $500 million building will consolidate cancer services and improve a patient's experience.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Abstract Human papillomaviruses (HPV) are small, double-stranded DNA viruses that cause cervical cancer, the second most lethal cancer among women in the world. Currently, two vaccines are on the market for preventing HPV-caused cervical cancers and warts. Both are virus-like particle (VLP)-based vaccines. However, these vaccines have limitations; they are costly, have an invasive route of administration, require trained personnel to administer, need cold chain storage to preserve them, and most of all, they are preventive vaccines that do not have curative effects. Therefore, it is necessary to develop therapeuti...
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Tags: J Pharm Pharm Sci Source Type: research
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Article Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Article Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Perspective Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Trends and Innovations Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Snapshot Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Best of the Rest Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Quiz Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Bone and Joint in Brief Source Type: news
More News: Computers | Economics | Emergency Medicine | Epidemiology | Funding | Grants | Politics | Psychology | Research | Science | Study | Warnings